Doximity (NYSE:DOCS) - 주가, 뉴스 및 분석

DOCS 주식 개요

는 미국의 의료 전문가를 위한 클라우드 기반 디지털 플랫폼을 운영합니다. 자세한 내용

DOCS 기본 분석
눈송이 점수
가치 평가	1/6
미래 성장	2/6
과거 실적	5/6
재무 상태	6/6
배당금	0/6

보상

가격 대비 수익 비율( 56 x)은 Healthcare Services 업계 평균( 56.2 x)보다 낮습니다.

수익은 매년 8.84% 증가할 것으로 예상됩니다.

지난 1년간 수익이 41.4% 증가했습니다.

위험 분석

최근 3개월간 주가 변동성

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Future Revenue Uncertainty Shadows Promising Client Portal And AI Advancements

Key Takeaways Client Portal rollout might not sustain expected revenue growth despite positive early adoption, raising concerns about future revenues. Emphasis on agency partnerships over direct sales may hinder long-term growth if they don't yield expected market share gains.

View narrative

US$50.80

2.8% overvalued

9.39%

Revenue growth p.a.

6 days ago

Doximity, Inc. 경쟁사

Veeva Systems

NYSE:VEEV

US$34.6b

HealthStream

NasdaqGS:HSTM

US$954.7m

Simulations Plus

NasdaqGS:SLP

US$577.3m

Masimo

NasdaqGS:MASI

US$8.6b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Doximity
과거 주가
현재 주가	US$52.21
52주 최고치	US$61.75
52주 최저치	US$22.96
베타	1.3
11개월 변경	20.02%
3개월 변경 사항	44.11%
1년 변경 사항	113.80%
33년 변화	-11.60%
5년 변화	n/a
IPO 이후 변화	-1.49%

최근 뉴스 및 업데이트

Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Nov 13

Recent updates

Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Nov 13

Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Nov 02

There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Aug 18

Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Aug 10

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Jul 23

Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

Jul 23

At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Jul 01

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Jun 09

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Mar 26

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Feb 13

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Jan 04

Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Dec 14

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 30

Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Sep 25

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Jul 29

Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Jul 09

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

The Returns At Doximity (NYSE:DOCS) Aren't Growing

Jun 21

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Apr 07

Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Mar 20

Doximity: Good Business But Extremely Overvalued

Feb 18

Doximity Q3 Earnings: Disappointing Results

Feb 10

주주 수익률

	DOCS	US Healthcare Services	US 마켓
7D	-14.8%	-10.1%	-2.1%
1Y	113.8%	5.6%	29.7%

수익률 대 산업: DOCS 지난 1년 동안 5.6 %를 반환한 US Healthcare Services 산업을 초과했습니다.

수익률 대 시장: DOCS 지난 1년 동안 29.7 %를 반환한 US 시장을 초과했습니다.

가격 변동성

Is DOCS's price volatile compared to industry and market?
DOCS volatility
DOCS Average Weekly Movement	10.7%
Healthcare Services Industry Average Movement	8.1%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.6%
10% least volatile stocks in US Market	3.1%

안정적인 주가: DOCS 의 주가는 지난 3개월 동안 변동성이 심했습니다.

시간에 따른 변동성: DOCS 의 주간 변동성( 11% )은 지난 1년 동안 안정적이었지만 여전히 US 의 75%보다 높습니다. 주식.

회사 소개

설립	직원	CEO	웹사이트
2010	827	Jeff Tangney	www.doximity.com

는 미국의 의료 전문가를 위한 클라우드 기반 디지털 플랫폼을 운영합니다. 이 회사의 플랫폼은 회원들에게 의료용으로 제작된 디지털 도구를 제공하여 동료와 협업하고, 최신 의학 뉴스와 연구 결과를 최신 상태로 유지하고, 경력 및 당직 일정을 관리하고, 문서 및 행정 서류 작업을 간소화하고, 가상 환자 방문을 수행할 수 있도록 지원합니다. 주로 의사, 전문간호사, 의사 보조원, 의대생, 제약 제조업체 및 의료 시스템에 서비스를 제공합니다.

Doximity, Inc. 기본 사항 요약

Doximity 의 수익과 매출은 시가총액과 어떻게 비교하나요?
DOCS 기본 통계
시가총액	US$9.22b
수익(TTM)	US$174.11m
수익(TTM)	US$516.85m

56.0x

P/E 비율

18.9x

P/S 비율

DOCS 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
DOCS 손익 계산서(TTM)
수익	US$516.85m
수익 비용	US$51.98m
총 이익	US$464.87m
기타 비용	US$290.76m
수익	US$174.11m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	0.93
총 마진	89.94%
순이익 마진	33.69%
부채/자본 비율	0%

DOCS 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

DOCS 주식 개요

보상

위험 분석

Future Revenue Uncertainty Shadows Promising Client Portal And AI Advancements

Doximity, Inc. 경쟁사

NYSE:VEEV

US$34.6b

NasdaqGS:HSTM

US$954.7m

NasdaqGS:SLP

US$577.3m

NasdaqGS:MASI

US$8.6b

가격 내역 및 성능

최근 뉴스 및 업데이트

Investor sentiment improves as stock rises 20%

Chief Financial Officer notifies of intention to sell stock

Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Doximity, Inc. Provides Earnings Guidance for Its Fiscal Third Quarter Ending December 31, 2024 and Updating Earnings Guidance for Its Fiscal Year Ending March 31, 2025

Independent Director notifies of intention to sell stock

Recent updates

Investor sentiment improves as stock rises 20%

Chief Financial Officer notifies of intention to sell stock

Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Doximity, Inc. Provides Earnings Guidance for Its Fiscal Third Quarter Ending December 31, 2024 and Updating Earnings Guidance for Its Fiscal Year Ending March 31, 2025

Independent Director notifies of intention to sell stock

Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Doximity, Inc. to Report Q2, 2025 Results on Nov 07, 2024

Price target increased by 8.5% to US$37.21

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity: Downgrade To Hold On Valuation Concerns

Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

Now 22% overvalued after recent price rise

There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Investor sentiment improves as stock rises 39%

Chief Financial Officer exercised options and sold US$1.1m worth of stock

Price target increased by 7.1% to US$31.64

Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

New minor risk - Share price stability

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Doximity, Inc. Provides Revenue Guidance for the Second Quarter Ending September 30, 2024 and Fiscal Year Ending March 31, 2025

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

Doximity, Inc., Annual General Meeting, Aug 29, 2024

Doximity, Inc. to Report Q1, 2025 Results on Aug 08, 2024

Now 29% undervalued

Now 28% undervalued

At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Now 22% undervalued after recent price drop

Chief Financial Officer notifies of intention to sell stock

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Investor sentiment improves as stock rises 18%

Doximity, Inc. Provides Financial Guidance for the First Quarter Ending June 30, 2024 and Full Year Ending March 31, 2025

Full year 2024 earnings released: EPS: US$0.78 (vs US$0.58 in FY 2023)

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

Doximity, Inc. (NYSE:DOCS) announces an Equity Buyback for $500 million worth of its shares.

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Doximity, Inc. to Report Q4, 2024 Results on May 16, 2024

Kessler Topaz Meltzer & Check, LLP Files Securities Fraud Class Action Lawsuit Against Doximity, Inc

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Doximity, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending March 31, 2024

Price target increased by 7.2% to US$28.17

Doximity, Inc. to Report Q3, 2024 Results on Feb 08, 2024

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Now 21% undervalued

Investor sentiment improves as stock rises 24%

Doximity, Inc. Provides Revenue Guidance for the Fiscal Third Quarter Ending December 31, 2023 and Fiscal Year Ending March 31, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Doximity, Inc. (NYSE:DOCS) announces an Equity Buyback for $70 million worth of its shares.

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism